232 related articles for article (PubMed ID: 14671133)
1. Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.
Chen SH; Pearson A; Coen DM; Chen SH
J Virol; 2004 Jan; 78(1):520-3. PubMed ID: 14671133
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
3. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
Wilcox CL; Crnic LS; Pizer LI
Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
[TBL] [Abstract][Full Text] [Related]
4. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
Besecker MI; Furness CL; Coen DM; Griffiths A
J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
[TBL] [Abstract][Full Text] [Related]
5. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
Friedrich A; Kleim JP; Schneweis KE
Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia.
Jacobson JG; Ruffner KL; Kosz-Vnenchak M; Hwang CB; Wobbe KK; Knipe DM; Coen DM
J Virol; 1993 Nov; 67(11):6903-8. PubMed ID: 8411396
[TBL] [Abstract][Full Text] [Related]
7. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.
Chen SH; Garber DA; Schaffer PA; Knipe DM; Coen DM
Virology; 2000 Dec; 278(1):207-16. PubMed ID: 11112495
[TBL] [Abstract][Full Text] [Related]
8. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.
Griffiths A; Chen SH; Horsburgh BC; Coen DM
J Virol; 2003 Apr; 77(8):4703-9. PubMed ID: 12663777
[TBL] [Abstract][Full Text] [Related]
9. Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.
Pan D; Pesola JM; Li G; McCarron S; Coen DM
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847363
[TBL] [Abstract][Full Text] [Related]
10. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
[TBL] [Abstract][Full Text] [Related]
11. Competition and complementation between thymidine kinase-negative and wild-type herpes simplex virus during co-infection of mouse trigeminal ganglia.
Chen SH; Lin YW; Griffiths A; Huang WY; Chen SH
J Gen Virol; 2006 Dec; 87(Pt 12):3495-3502. PubMed ID: 17098963
[TBL] [Abstract][Full Text] [Related]
12. Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.
Tenser RB; Jones JC; Ressel SJ
J Infect Dis; 1985 Mar; 151(3):548-50. PubMed ID: 2982968
[No Abstract] [Full Text] [Related]
13. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
14. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
Tenser RB; Gaydos A; Hay KA
J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
[TBL] [Abstract][Full Text] [Related]
16. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
Leib DA; Coen DM; Bogard CL; Hicks KA; Yager DR; Knipe DM; Tyler KL; Schaffer PA
J Virol; 1989 Feb; 63(2):759-68. PubMed ID: 2536101
[TBL] [Abstract][Full Text] [Related]
17. Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion.
Kramer M; Riley J; Spoering A; Coen D; Knipe D
Curr Eye Res; 2003; 26(3-4):185-94. PubMed ID: 12815546
[TBL] [Abstract][Full Text] [Related]
18. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
19. Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.
Pelosi E; Mulamba GB; Coen DM
Antiviral Res; 1998 Jan; 37(1):17-28. PubMed ID: 9497069
[TBL] [Abstract][Full Text] [Related]
20. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.
Chen SH; Lee LY; Garber DA; Schaffer PA; Knipe DM; Coen DM
J Virol; 2002 May; 76(10):4764-72. PubMed ID: 11967293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
